Jeffrey Chodakewitz Net Worth & Insider Trades
Jeffrey Chodakewitz - EVP, Vertex Pharmaceuticals Inc / Ma
What is Jeffrey Chodakewitz's Net Worth?
The current estimated net worth of Vertex Pharmaceuticals Inc / Ma's EVP, Jeffrey Chodakewitz, is estimated to be about $49.9M . Jeffrey Chodakewitz owns about 69,663 units of Vertex Pharmaceuticals Inc / Ma common stock. In the last 4 years at Vertex Pharmaceuticals Inc / Ma, Jeffrey Chodakewitz has sold an estimated value of $30.85M worth.
What is Jeffrey Chodakewitz's Past Insider Trading?
Jeffrey Chodakewitz's largest purchase order was 38,646 units , worth over $4.14M on July 21, 2017. Jeffrey Chodakewitz's largest sale order was 60,000 units , worth over $8.7M on October 31, 2017. In total, Jeffrey Chodakewitz has made about 36 transactions over 4 years of their time at Vertex Pharmaceuticals Inc / Ma. Jeffrey Chodakewitz usually trades in February, with the busiest year in 2017. The most recent transaction was a sale order of 5,122 units , worth over $772.49K on February 14, 2018.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Jeffrey Chodakewitz
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
InsideArbitrage
What is Jeffrey Chodakewitz's' Mailing Address?
- Mailing address is C/o Tetraphase Pharmaceuticals, Inc. 480 Arsenal St., Suite 101 Watertown MA 02472 MA
What are Vertex Pharmaceuticals Inc / Ma's Past Insider Trades?
Vertex Pharmaceuticals Inc / Ma's most recent insider trade came on November 21, 2023 by Charles Wagner Jr who sold 3,000 units worth $1.05M . In the last 20 years, insiders at Vertex Pharmaceuticals Inc / Ma have sold an estimated value of $1.81B and bought an estimated value of $541.77M worth of shares. Insider trading is most common in February, with the busiest year in 2015. The most active traders at the company are Joshua Boger, Director, Paul Silva, SVP & Chief Accounting Officer, and Amit Sachdev, EVP Chief Patient & Ext Af Off .
VERTEX PHARMACEUTICALS INC / MA Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |